Medite Cancer Diagnostics, Inc.
company.status.inactiveCIK 75439fmd_0VQQZY2X9EDVKC1VBZHM5BKCHKManufacturing · Surgical & Medical Instruments & ApparatusTemplate: Standard
Coverage: Jan 01, 2010 to Sep 30, 2018, 34 periods
| Line item | FY2010 | FY2011 | FY2012 | FY2013 | FY2014 | FY2015 | FY2016 | FY2017 |
|---|---|---|---|---|---|---|---|---|
| Total revenues | 0 | 0 | 0 | 10 | 11 | 10 | 9 | 7 |
| Cost of revenue | 0 | 0 | 0 | 6 | 7 | 6 | 6 | 7 |
| Gross profit | 0 | 0 | 0 | 4 | 4 | 4 | 4 | 0 |
| Research and development | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 1 |
| Selling, general and administrative | 2 | 2 | 1 | 1 | – | – | – | – |
| Operating income | (2) | (3) | (1) | 0 | (0) | (1) | (2) | (6) |
| Interest and investment income | – | – | – | 0 | 0 | – | – | – |
| Other non-operating income (expense) | 0 | (0) | (0) | (0) | (0) | (0) | (1) | (1) |
| Income before taxes | (2) | (3) | (2) | 0 | (1) | (1) | (2) | (7) |
| Income tax expense | – | 0 | 0 | 0 | 0 | 0 | (0) | (0) |
| Net income from continuing operations | – | (3) | (2) | 0 | (1) | (1) | (2) | (7) |
| Net income | (2) | (3) | (2) | 0 | (1) | (1) | (2) | (7) |
| Net income to common shareholders | (2) | (3) | (2) | 0 | (1) | (1) | (2) | (7) |